Qulipta Dosage
Generic name: ATOGEPANT 10mg
Dosage form: tablet
Drug class: CGRP inhibitors
Medically reviewed by Drugs.com. Last updated on Oct 12, 2021.
2.1 Recommended Dosage
The recommended dosage of QULIPTA is 10 mg, 30 mg, or 60 mg taken orally once daily with or without food.
2.2 Dosage Modifications
Dosing modifications for concomitant use of specific drugs and for patients with renal impairment are provided in Table 1.
Table 1: Dosage Modifications for Drug Interactions and for Specific Populations
Dosage Modifications | Recommended Once Daily Dosage |
Concomitant Drug [see Drug Interactions (7)] | |
Strong CYP3A4 Inhibitors (7.1) | 10 mg |
Strong and Moderate CYP3A4 Inducers (7.2) | 30 mg or 60 mg |
OATP Inhibitors (7.3) | 10 mg or 30 mg |
Renal Impairment [see Use in Specific Populations (8)] | |
Severe Renal Impairment and End-Stage Renal Disease (CLcr <30 mL/min) (8.6) |
10 mg |
Frequently asked questions
- What are the new drugs for the treatment of migraines?
- How do Ubrelvy, Qulipta and Nurtec compare for migraines?
More about Qulipta (atogepant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (36)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: CGRP inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.